Skip to main content
OpenTrials

Clinical trial condition

Non Follicular Indolent Non-Hodgkin Lymphoma

Explore clinical trials studying Non Follicular Indolent Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Non Follicular Indolent Non-Hodgkin Lymphoma trial results

Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

NCT03364231

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details

Related conditions